AB-CHMINACA is an indazole-based synthetic cannabinoid. It is a potent agonist of the CB₁ receptor and CB₂ receptor and fully substitutes for Δ⁹-THC in rat discrimination studies, while being 16x more.
AB-FUBINACA was initially synthesized by Pfizer, Inc. as an effective powerful CB1 receptor modulator for possible therapeutic usage, however not too long ago had been discovered together with AB-PINACA in prohibited herbal products.
AB-CHMINACA is structurally relevant to AB-FUBINACA which includes a cyclohexyl group replaced for the 4-fluorophenyl group. The physical and toxicological attributes associated with the substance haven’t been identified. The product was created for research and forensic purposes.
This research chemical is not intended for human consumption. This cannabinoid ship direct from our lab to any country in the world. Buy AB-CHMINACA ONLINE a rare compound very difficult to acquire. If the quality specifications attached to the requirements are especially tough then finding a particular compound can become even more difficult.Buy AB-CHMINACA online is one such compound.
AB-CHMINACA is an indazole-based synthetic cannabinoid. It is a potent agonist
of the CB1 receptor (Ki = 0.78 nM) and CB2 receptor (Ki = 0.45 nM) and fully
substitutes for Δ9-THC in rat discrimination studies, while being 16x more potent.
Continuing the trend seen in other cannabinoids of this generation, such as AB-FUBINACA and AB-PINACA,
it contains a valine amino acid amide residue as part of its structure, where older cannabinoids contained a naphthyl or adamantane residue.
|Synthetic cannabinoid receptor agonists|
This substance is included in Schedule II of the 1971 Convention on Psychotropic Substances.